標(biāo)題: Titlebook: Impact of TRIPS in India; An Access to Medicin Prabodh Malhotra Book 2010 Palgrave Macmillan, a division of Macmillan Publishers Limited 20 [打印本頁(yè)] 作者: implicate 時(shí)間: 2025-3-21 16:55
書(shū)目名稱Impact of TRIPS in India影響因子(影響力)
書(shū)目名稱Impact of TRIPS in India影響因子(影響力)學(xué)科排名
書(shū)目名稱Impact of TRIPS in India網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Impact of TRIPS in India網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Impact of TRIPS in India被引頻次
書(shū)目名稱Impact of TRIPS in India被引頻次學(xué)科排名
書(shū)目名稱Impact of TRIPS in India年度引用
書(shū)目名稱Impact of TRIPS in India年度引用學(xué)科排名
書(shū)目名稱Impact of TRIPS in India讀者反饋
書(shū)目名稱Impact of TRIPS in India讀者反饋學(xué)科排名
作者: CAGE 時(shí)間: 2025-3-21 22:06
Prabodh Malhotraht. Dansylsarkosin (DS) assoziiert spezifisch an der Benzodiazepinbindungsseite von Humanserumalbumin und dient als Modelligand. Die Bestimmung der Bindungskinetik erfolgte in einer Durrum-Gibson Stopped-flow Apparatur über die Aufzeichnung des Zeitverlaufs der Fluoreszenz von Dansylsarkosin w?hrend作者: Amorous 時(shí)間: 2025-3-22 03:27 作者: 上腭 時(shí)間: 2025-3-22 06:43 作者: Airtight 時(shí)間: 2025-3-22 12:47 作者: Duodenitis 時(shí)間: 2025-3-22 15:50
about 12%-15% of the population in the Western world, and the total number of the elderly will increase significantly in the coming years. This population accounts for 30% of all the prescription drugs used. Aging, specifically the transition from middle to old age, is a complex process. From the p作者: 蝕刻 時(shí)間: 2025-3-22 20:35 作者: SLUMP 時(shí)間: 2025-3-22 23:21 作者: 陰郁 時(shí)間: 2025-3-23 05:18
Prabodh Malhotrant by Jackson, one could say today: "He who is faithfully analysing anti-epileptic drugs is doing far more than studying anti-epileptic drugs". For these drugs not only serve to prevent epileptic fits and thus advance the treatment of epilepsy, they are also effective in the treatment of cardiac arr作者: 刺耳 時(shí)間: 2025-3-23 08:36
Prabodh Malhotrant by Jackson, one could say today: "He who is faithfully analysing anti-epileptic drugs is doing far more than studying anti-epileptic drugs". For these drugs not only serve to prevent epileptic fits and thus advance the treatment of epilepsy, they are also effective in the treatment of cardiac arr作者: 搖曳的微光 時(shí)間: 2025-3-23 12:40 作者: 圓柱 時(shí)間: 2025-3-23 16:48
ficult to mimic human disease in animal experiments. Human disease is, in most instances, a multifactorial event, which runs an individual course in each patient, with a variable outcome. The aim of an experimental model of a disease should, therefore, be to include the main pathogenetic factors for作者: Cytokines 時(shí)間: 2025-3-23 19:19
Prabodh Malhotraeed on the condition that, in accordance with my scientific background, primary emphasis be given to clinical pharmacology and therapeutics. It soon turned out that, due to rapid developments in this field, nothing of the previous volume on Antianginal Drugs by Charlier (Vol. 31, 1971) could be reta作者: 使高興 時(shí)間: 2025-3-23 22:54 作者: 共同生活 時(shí)間: 2025-3-24 03:44
Prabodh Malhotraeed on the condition that, in accordance with my scientific background, primary emphasis be given to clinical pharmacology and therapeutics. It soon turned out that, due to rapid developments in this field, nothing of the previous volume on Antianginal Drugs by Charlier (Vol. 31, 1971) could be reta作者: 按時(shí)間順序 時(shí)間: 2025-3-24 07:06
bstances. Sir Henry Dale (1906) observed the next year that while the excitatory actions of adrenaline were blocked by ergot, the inhibitory ones were not, providing evidence for two types of adrenergic receptors. Then in 1948 A. published his now classical paper in the . where he studied the effect作者: gastritis 時(shí)間: 2025-3-24 11:02
Introductionin particular, on the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). A number of experts have studied the impact of implementing the TRIPS agreement in India (see for example Galpalli 2004; Lanjouw 1998; Scherer and Watal 2001). However, the impact of TRIPS in India is m作者: 抵制 時(shí)間: 2025-3-24 17:27
The WTO and the TRIPS Agreements including the umbrella agreement that established the World Trade Organization (WTO 2010). Besides establishing a framework for dispute settlement and trade policy reviews, the agreements covered the following major areas. The General Agreement on Tariffs and Trade (GATT) that existed since 1947 w作者: 揭穿真相 時(shí)間: 2025-3-24 22:33 作者: 小淡水魚(yú) 時(shí)間: 2025-3-24 23:13 作者: Between 時(shí)間: 2025-3-25 04:14 作者: 忘川河 時(shí)間: 2025-3-25 08:53
Price Controls and Drug Affordability in India: Policy Options systems cannot rely entirely on market mechanisms for healthcare delivery. Price controls are a method of regulating drug prices for achieving health policy goals (Gray & Matsebula 2003). The governments use interventions from the supply side by controlling drug prices and/or from the demand side b作者: 多嘴多舌 時(shí)間: 2025-3-25 14:26
Health Insurance in India 207). Most of the industrialised nations, except the US, and a small number of developing countries, provide health insurance programmes to cover most of their populations for substantial share of their health expenditure including pharmaceuticals. In the US, the public health insurance (Medicaid, 作者: disciplined 時(shí)間: 2025-3-25 17:39
Broadening Access to Medicines and Healthcare in Indiae literature. This group of people is too rich to belong to the BPL families and too poor to belong to the middle-class Indians. The 300 million strong middle-class (M-class) Indians are the primary target for marketers and often acknowledged in the global media. The around 350. million estimated po作者: 大溝 時(shí)間: 2025-3-25 20:07 作者: 過(guò)去分詞 時(shí)間: 2025-3-26 01:34 作者: 束以馬具 時(shí)間: 2025-3-26 05:37
Final Conclusions deals with the impact of the TRIPS agreement on the pharmaceutical industry and the access to medicines in India, acknowledging that the introduction of the TRIPS compliant regime from 1 January 2005 marked a major shift in India’s public policy on the protection of intellectual property rights (IP作者: promote 時(shí)間: 2025-3-26 08:43 作者: Ostrich 時(shí)間: 2025-3-26 15:48
Broadening Access to Medicines and Healthcare in Indiaation in the BPL2 group and lower end of middle class group mostly get into irrecoverable debts in health crisis. India’s healthcare would be incomplete without addressing the needs of all three segments of the community.作者: 召集 時(shí)間: 2025-3-26 17:48
Which Way Ahead?. Of all the intellectual property within TRIPS, the issue of pharmaceutical product patents has been the most controversial one (Alsegard 2004). However, the TRIPS agreement is a set of rules on which all WTO members agreed. It may not suit the circumstances and interests of every member state; nevertheless, it is an agreed set of rules.作者: 倒轉(zhuǎn) 時(shí)間: 2025-3-26 21:22
Price Controls and Drug Affordability in India: Policy Optionsy restricting reimbursements and by raising patient co-payments (Cai & Salmon 2005). From the manufacturers’ perspective, price controls restrict free market activity, limit profits, and restrict return on investment.作者: Ingrained 時(shí)間: 2025-3-27 04:14 作者: 創(chuàng)造性 時(shí)間: 2025-3-27 08:05
Development of India’s Pharmaceutical Industryaccess to medicines in India as well as in other low- and middle-income countries (LMICs). A number of policies introduced in the 1970s (discussed later in the chapter) underpinned this growth from a virtually non-existent pharmaceutical industry to becoming the world’s largest producer of generics.作者: 消毒 時(shí)間: 2025-3-27 09:30
TRIPS and the Indian Patents Regimerial framework. The first Act relevant to the modern pharmaceutical industry was the Indian Patents and Designs Act 1911. This Act provided patents for pharmaceutical . and . and . for 16 years extendable by another ten years if the patent had not generated sufficient returns for the patent holder (Lalitha 2002).作者: 勉強(qiáng) 時(shí)間: 2025-3-27 16:05 作者: pacific 時(shí)間: 2025-3-27 18:17 作者: harpsichord 時(shí)間: 2025-3-27 22:43
Health Insurance in Indiad increased price controls in the US has gained momentum in recent years. However, experts such as Santerre and Vernon (2006) oppose the introduction of drug price controls in the US and argue that such a move would result in much higher costs than benefits to the society.作者: 現(xiàn)暈光 時(shí)間: 2025-3-28 02:48 作者: CONE 時(shí)間: 2025-3-28 07:48
978-1-349-32348-7Palgrave Macmillan, a division of Macmillan Publishers Limited 2010作者: Magnitude 時(shí)間: 2025-3-28 14:08 作者: BATE 時(shí)間: 2025-3-28 15:39 作者: 斑駁 時(shí)間: 2025-3-28 20:26 作者: 遵循的規(guī)范 時(shí)間: 2025-3-29 00:25 作者: avarice 時(shí)間: 2025-3-29 03:05
Prabodh Malhotraly intervention in acute myocardial infarction. Here, intracoronary streptokinase therapy and PTCA are considered, again with attention to the overlap between m978-3-642-69526-1978-3-642-69524-7Series ISSN 0171-2004 Series E-ISSN 1865-0325 作者: theta-waves 時(shí)間: 2025-3-29 08:41 作者: SLUMP 時(shí)間: 2025-3-29 11:55
The WTO and the TRIPS Agreementregional and bilateral agreements on investment, free trade, and other disciplines have forced developing countries to raise protection standards for intellectual property beyond what is required under TRIPS. These higher protection standards, known in the literature as TRIPS-plus conditions, restri作者: Subdue 時(shí)間: 2025-3-29 16:43 作者: Eructation 時(shí)間: 2025-3-29 21:42
Prabodh Malhotraer Assoziationsgeschwindigkeitskonstanten k. (r. = 0,59; P < 0,001). Im Serum von Neugeborenen (Mittelwert: k. = 300 s., n = 32) ist k. gr??er als im Serum von Erwachsenen im Alter von 23?65 Jahren (k. = 200 s.; n = 28, P < 0,001) und von Erwachsenen im Alter von 66?101 Jahren (k. = 144 s.; n = 24,
